Represented Flying L Partners II, LLC with its $25 million investment in Series H Preferred Stock of RxSight, Inc. Bill Link, leader of Flying L Partners’, acted as lead investor through Flying L Partners/RxSight, LLC. RxSight has raised over $46 million in Series H financing.
Flying L Partners is a sponsor of investment funds that focus their investments in medical devices and in particular the ophthalmic space. RxSight, Inc. is a global leader in adjustable intraocular technology that enables doctors and patients to enhance vision after cataract surgery.
The deal team representing Flying L Partners included Bruce Feuchter on the fund formation side and Jeff Estes on the investment side.